Dr. Edem S. Agamah, MD

Dr. Agamah practices at Siu Healthcare in Springfield, Illinois.

Dr. Agamah's NPI, 1932147279, was assigned on June 2, 2006. Dr. Agamah graduated from University of Ghana Medical School in 1985. Dr. Agamah holds Illinois license 036085000.

Dr. Agamah's primary practice is Siu Healthcare, at 315 W Carpenter St Fl 1 Fl 1, Springfield, IL 62702. The practice phone is (217) 545-8000.

Dr. Agamah's primary practice is Siu Healthcare in Springfield, Illinois. Dr. Agamah is also affiliated with Springfield Memorial Hospital. The medical group on file is SIU Medicine. Dmand AI also links Dr. Agamah to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agamah practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Agamah's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agamah is board certified in internal medicine by the American Board of Internal Medicine. Dr. Agamah is licensed in Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Agamah treats.

CMS data shows 29,058 Medicare services from Dr. Agamah across 22 procedure codes in 2024, for 365 Medicare patients. Medicare paid $653,955 for them. Every service was in an office.

CMS counts 365 Medicare patients who saw Dr. Agamah in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agamah's median patient age at 70, with 59% women.

In 2024, Dr. Agamah wrote 1,195 Medicare Part D claims for 177 patients. 77% of them were for generic drugs. CMS names the drug for 903 of them, across 34 drugs with 11 or more claims each, at $2,515,433 in total drug cost. In 2023, CMS named 751 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Agamah for performance year 2024, reported as part of a group. Dr. Agamah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Agamah, published from 2006 to 2024. 2010 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Antineoplastic Agents. Dr. Agamah's most frequent co-authors are Krishna C. Alluri, MD, Bruce Earl Brockstein, MD and Lauren Averett Byers, MD.

Dmand AI links Dr. Agamah to 15 clinical trials, 10 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Prostatic Neoplasms and Liver Neoplasms. National Cancer Institute (NCI) sponsors the most, 14.

CMS Open Payments shows 7 general payments to Dr. Agamah from 3 drug and device companies from 2018 to 2025. Education make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $450.

Dmand AI lists 1 award for Dr. Agamah, most recently ACP Fellow in 2001.

Dr. Agamah graduated from University of Ghana Medical School in 1985. Dr. Agamah is a member of ACP and ASCO.

Dr. Agamah is in network with 10 carriers, including Aetna, HCSC and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.